Rosebud Biosciences develops therapies for rare genetic diseases in children using organoids that model human development and replicate genetic mutations.
Founded
2020
Company Stage
Pre-Seed
YC Batch
W22
Product Features & Capabilities
Organoid platform, targeted therapies for rare genetic diseases, cardiac organoids, hepatic organoids, neural organoids, kidney organoids, drug screening using human induced pluripotent stem cells (hiPSCs), mutation-specific organoid models.
